Full List Of Stories
Sector movers: Cyclicals pace gains on US stimulus hopes, vaccine news
Cyclicals paced the advance on Tuesday helped by news that Democrats in the US were willing to go it alone on approving further fiscal stimulus if needed through recourse to so-called 'budget reconciliation'.
UN chief makes case for increasing access to vaccines globally
The head of the United Nations warned that it was in the self-interest of countries in the Northern Hemisphere to help those in the South to access vaccines.
Europe close: Stocks bounce back on hopes for US stimulus, J&J vaccine
European shares rebounded on Tuesday as investors shrugged off concerns over tighter coronavirus travel restrictions and the slower pace of vaccine rollouts across the Continent.
Wednesday preview: Federal Reserve, Apple in focus
Financial markets are likely to be in a holding pattern on Wednesday, as investors wait on the results of the Federal Reserve's policy meeting after the close of trading in London.
Regeneron Pharmaceuticals Covid-19 antibodies 100% effective in blocking infections
Regeneron Pharmaceuticals antibody cocktail severely curtails Covid-19 symptoms and infections, the results of a late-stage trial showed.
Johnson and Johnson expects Covid-19 trial results early next week
Johnson&Johnson expects the results of the eagerly awaited late-stage clinical trial results for its Covid-19 vaccine candidate early during the following.
US consumer confidence edges past forecasts in January, Conference Board says
Consumer sentiment in the US was buoyed by gains in the stock market and federal stimulus checks at the start of 2020.
US house price growth outpaces economists' forecasts in November
The Federal Housing Finance Agency's national House Price Index notched up a month-on-month rise of 1. 0%, which pushed the year-on-year rate of increase to 11. 0% (consensus: 10. 4%).